Note Summary:
PLC reported a 17% YoY decline in earnings for 3QFY17, arising mainly from a higher cost to income ratio (+4ppt YoY to 54%) amid an increase in operating expenses (+18% YoY) and a shrinking of NIMs (currently at ~8% vs. ~9% last year). Admin costs related to branch expansion (eleven new branches opened in 9MFY17) have mainly driven the increase in operating expenses, while the contraction in NIMs stems from an expected sector wide increase in funding costs amid an asset-liability maturity mismatch. Given a lack of liquidity in the system, PLC has had to increase its exposure to fixed deposits in FY17 and now offers a rate of 13% on a one year FD. PLC has been less impacted than some of its peers by a slowdown in new vehicle registrations, as the company is more exposed to the dual purpose and hybrid vehicle category which has not been as affected as the small car and three wheeler category. This, coupled with an increase in second hand vehicle demand, and growth in other loan products (such as the company’s ‘Fast Track’ short term working capital loan scheme), has driven healthy net loan book growth of 21% for 9MFY17.
With 9MFY17 earnings at Rs. 3.2bn (-10% YoY), PLC is on track to achieve our full year earnings projection of Rs. 4.1bn (-13% YoY). At its current price of Rs. 16.60, PLC trades at a FY17E P/E of 6.4x and a P/BV of 1.1x (based on Dec 2016 NAVPS), at a slight premium to our NBFI coverage universe. The company has already paid an interim dividend of Rs. 0.75 per share and should maintain its historical full year dividend payment of Rs. 1.25 per share for FY17, translating to a generous 8% dividend yield.
•JKSB is one of 15 founding members of the Colombo Stock Exchange with roots in share trading dating back to 1896, and is a subsidiary of John Keells Holdings PLC (JKH), the largest listed entity on the Colombo Stock Exchange with a market capitalization of US$ 1.3bn.
•JKSB’s core client base is Foreign Institutional Investors, Local Institutions and HNWI’s
•JKSB has a co-branded Research tie up with CIMB and a Research Referral agreement with Credit Suisse, along with trade execution relationships with several other global and regional securities firms.
•JKSB’s trade execution partners include Credit Suisse, CIMB, Merrill Lynch, Exotix, Daiwa, Convergex, Deutsche Asia Securities and Morgan Stanley
•JKSB is a research contributor to Bloomberg on ‘KEEL’
•The JKSB Research Universe covers 72 stocks across 15 sectors, with most Research efforts focused on approximately 45 of the more liquid counters.
•The JKSB Universe constitutes 67% of total market cap and approximately 80% of turnover at the CSE.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.